Evidence map›Paper›PMID 40991324›Full record

ArticleBioinformatics (Oxford, England)2025

PTL-PRS: an R package for transfer learning of polygenic risk scores with pseudovalidation.

Bokeum Cho, Seunggeun Lee

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bokeum ChoGraduate School of Data Science, Seoul National University, Seoul 08826, South Korea.
Seunggeun LeeGraduate School of Data Science, Seoul National University, Seoul 08826, South Korea.ORCID 0000-0002-8097-3878

Funding

Brain Pool Plus (BP+) Program of the National Research Foundation of Korea (NRF)Ministry of Health and Welfare, Republic of Korea RS-2025-02307233Ministry of Science and ICT, Republic of Korea 2020H1D3A2A03100666the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
6 · The paper itself

Abstract

summaryPolygenic risk scores (PRSs) are essential tools for predicting individual phenotypic risk but often lack accuracy in non-European ancestry groups. Transfer Learning for Polygenic Risk Scores (TL-PRS) addresses this challenge by leveraging European PRSs to improve prediction in underrepresented ancestries but requires privacy-sensitive individual-level data and has low computational efficiency. Therefore, we introduce Pseudovalidated Transfer Learning for PRS (PTL-PRS), an extension of TL-PRS that incorporates pseudovalidation to eliminate the need for individual-level data and includes further software optimization. For pseudovalidation, PTL-PRS generates pseudo-summary statistics for training and validation and evaluates model performance with the pseudo-R2 metric. To improve computational efficiency, PTL-PRS software was optimized with C++, blockwise early stopping, and direct genotype retrieval. Overall, PTL-PRS enhances usability while maintaining TL-PRS's predictive performance. AVAILABILITY AND IMPLEMENTATION: The PTL.PRS R package is publicly available on GitHub at https://github.com/bokeumcho/PTL.PRS. The summary statistics used in this paper are available in the public domain: UK Biobank (https://pheweb.org/UKB-TOPMed), PGS Catalog (https://www.pgscatalog.org), COVID-19 Host Genetics Initiative (https://www.covid19hg.org) and GenOMICC (https://genomicc.org/data).

Indexed as

Machine LearningMultifactorial InheritanceSoftwareCOVID-19Genetic Predisposition to DiseaseGenetic Risk ScoreHumans

Identifiers

PMID40991324
PMCPMC12529095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.